NCT00958854View on ClinicalTrials.gov

Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma

PHASE2UnknownINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2012

Conditions

Lymphoma

Interventions

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

DRUG

thalidomide

OTHER

laboratory biomarker analysis

Trial Locations (1)

EX2 5DW

RECRUITING

Cancer Research UK and University College London Cancer Trials Centre, Exeter

Sponsors

Lead Sponsor

Cancer Research UK

All Listed Sponsors

lead

Cancer Research UK

OTHER